Dogs and humans alike can suffer from a rare bleeding disorder called factor VII deficiency, where lacking a vital coagulation protein, factor VII, can lead to extensive bleeding in the central ...

Purpose. Unlabeled uses of factor VIIa (recombinant) in pediatric patients are reviewed. Summary. Factor VIIa (recombinant) is currently approved for the treatment and prevention of bleeding in ...

Factor VII deficiency is a rare, autosomal recessive bleeding disorder marked by reduced levels or dysfunction of coagulation factor VII, a crucial initiator of the extrinsic coagulation cascade.

Hematology researchers have used a single injection of gene therapy to correct a rare bleeding disorder, factor VII deficiency, in dogs. This success in large animals holds considerable potential for ...

AN elevated prothrombin time as determined by the Quick 1 procedure may be due to many abnormalities, including deficiency of factors I (fibrinogen), II (prothrombin), V (achéal-globulin), VII ...

A single injection. That's all someone with a factor VII deficiency would need for a life-long cure, thanks to a new gene therapy treatment developed in a collaboration of researchers at the ...

Rare clotting factor deficiencies are a collection of bleeding disorders associated with issues with clotting factors. These conditions are inherited and target the proteins in the blood that control ...

Hematology researchers have used a single injection of gene therapy to correct a rare bleeding disorder, factor VII deficiency, in dogs. This success in large animals holds considerable potential for ...